ABSTRACT
Asplenic or hyposplenic patients are at risk of fulminant sepsis. This entity has a mortality of up to 50%. The spectrum of causative organisms is evolving as are recommended preventive strategies, which include education, prophylactic and standby antibiotics, preventive immunizations, optimal antimalarial advice when visiting endemic countries and early management of animal bites. However, there is evidence that adherence to these strategies is poor. Consensus-updated guidelines have been developed to help Australian and New Zealand clinicians and patients in the prevention of sepsis in asplenic and hyposplenic patients.
Subject(s)
Practice Guidelines as Topic/standards , Sepsis/prevention & control , Splenic Diseases/therapy , Animals , Humans , Sepsis/epidemiology , Sepsis/etiology , Splenectomy/methods , Splenic Diseases/complications , Splenic Diseases/epidemiologySubject(s)
Drug Resistance, Bacterial , Meningococcal Infections/drug therapy , Penicillin G/administration & dosage , Adult , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Humans , Infusions, Intravenous , Male , Meningococcal Infections/diagnosis , Penicillin G/adverse effects , Prognosis , Risk Assessment , Time Factors , Treatment Failure , Treatment OutcomeABSTRACT
Very few studies of the quality of electronic mailing lists have been published. Ozbug was established in 1997 as a moderated and closed mailing list for infectious diseases physicians in Australia and New Zealand. A broad range of clinical and professional issues is discussed by -subscribers. An email survey of subscribers in 2002 indicated a high degree of satisfaction with the service.
